Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 16:05 | 5/15/24 | GERN | Health | Drug | Pharmaceutical Preparations | Lawlis V Bryan | CA | D | S.d | -131 | 3.75 | 0 | -35 | -100 | 0 | D | |||||||||||||||
5/11/23 21:01 | 5/11/23 | GERN | Health | Drug | Pharmaceutical Preparations | Lawlis V Bryan | CA | D | S.d | -105 | 3.00 | 0 | -35 | -100 | 0 | D | |||||||||||||||
5/1/23 21:20 | 5/1/23 | GERN | Health | Drug | Pharmaceutical Preparations | Molineaux Susan | CA | D | S.d | -87 | 2.48 | 0 | -35 | -100 | 0 | D | |||||||||||||||
2/10/23 21:49 | 2/9/23 | GERN | Health | Drug | Pharmaceutical Preparations | Grethlein Andrew J | CA | O | EVP,COO | S.d | -1,166 | 3.03 | 0 | -385 | -100 | 0 | D | ||||||||||||||
2/10/23 21:48 | 2/8/23 | GERN | Health | Drug | Pharmaceutical Preparations | Bloom Olivia Kyusuk | CA | O | EVP,CFO | S.d | -1,232 | 3.08 | 0 | -400 | -84 | 75 | D | ||||||||||||||
2/10/23 21:47 | 2/8/23 | GERN | Health | Drug | Pharmaceutical Preparations | Scarlett John A | CA | DO | CB,P,CEO | S.dm | -4,069 | 3.04 | 0 | -1,340 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |